Please login to the form below

Not currently logged in
Email:
Password:

drug-device combinations

This page shows the latest drug-device combinations news and features for those working in and with pharma, biotech and healthcare.

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn. The deal will see it focus on a series of drug-device combinations for Parkinson’s disease, headed by phase III candidate ND0612. ... The $39-per-share deal will see NeuroDerm merged with Mitsubishi's

Latest news

  • Medtronic and Samsung partner on diabetes device Medtronic and Samsung partner on diabetes device

    Medtronic and Samsung partner on diabetes device. Alliance will develop app to monitor glucose and insulin information. ... In addition to this, Sanofi also worked with Medtronic to develop drug device combinations for patients with type 2 diabetes. .

  • Sanofi and Medtronic to develop drug-device combos in diabetes Sanofi and Medtronic to develop drug-device combos in diabetes

    Sanofi and Medtronic to develop drug-device combos in diabetes. Companies tell PMLiVE their new alliance will take an ‘ open innovation’ approach. ... Sanofi has entered a partnership with US-based medical device firm Medtronic to develop drug-device

  • Drug-device convergence Drug-device convergence

    Drug-device combinations have been around for more than 50 years, with transdermal patches delivering drugs, stents coated with anticoagulants, inhaled medicines and drugs bundled alongside diagnostics all coming under the ... All told, the global market

  • MHRA launches virtual 'innovation office' MHRA launches virtual 'innovation office'

    The UK regulator wants to help firms working on things like novel drug-device combinations or nanomedicines to navigate its regulatory processes through early dialogue. ... Areas of technology that are a current focus for the regulator include novel

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Spectrum Regulatory Solutions

    We serve the following industry segments: pharmaceutical, biologics, medical devices, drug device combinations, nutraceuticals, functional foods and veterinary.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics